These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2468502)

  • 1. Serological detection and molecular localization of allelic HLA-DP supertypic epitopes.
    Colonna M; Tanigaki N; Tosi R; Ferrara GB
    Eur J Immunol; 1989 Mar; 19(3):433-40. PubMed ID: 2468502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
    Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
    Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci.
    Bugawan TL; Horn GT; Long CM; Mickelson E; Hansen JA; Ferrara GB; Angelini G; Erlich HA
    J Immunol; 1988 Dec; 141(11):4024-30. PubMed ID: 2460556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A newly characterized HLA-DP beta-chain allele. Evidence for DP beta heterogeneity within the DPw4 specificity.
    Lair B; Alber C; Yu WY; Watts R; Bahl M; Karr RW
    J Immunol; 1988 Aug; 141(4):1353-7. PubMed ID: 2456351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in specificity of "DPw2-specific" cytotoxic T cell clones revealed with HLA-mutant lines: evidence that non-DP HLA genes influence recognition by some clones.
    Sánchez Pérez M; Diez Orejas R; Petersen JW; De Mars R; Shaw S
    Eur J Immunol; 1990 Mar; 20(3):673-81. PubMed ID: 2108045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
    J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A supertypic HLA-DP specificity defined by two human-human hybridoma antibodies (TrB50; TrE11).
    Kolstad A; Hannestad K
    Hum Immunol; 1989 Aug; 25(4):247-56. PubMed ID: 2788637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope recognition by a DP alpha chain-specific monoclonal antibody (DP11.1) is influenced by the interaction between the DP alpha chain and its polymorphic DP beta chain partner.
    Young JA; Lindsay J; Bodmer JG; Trowsdale J
    Hum Immunol; 1988 Sep; 23(1):37-44. PubMed ID: 2461352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of HLA-DP specificities HLA-DPw1, -DPw2 and -DPw4: DP beta chain heterogeneity correlates with PLT subtyping.
    Baas EJ; Bontrop RE; Otting N; Giphart MJ
    Tissue Antigens; 1988 Jan; 31(1):5-13. PubMed ID: 2829386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-chain gene rearrangements and V beta gene usage in DPw2-specific T cells.
    Beall SS; Lawrence JV; Bradley DA; Mattson DH; Singer DS; Biddison WE
    J Immunol; 1987 Aug; 139(4):1320-5. PubMed ID: 3039001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "new" supertypic HLA-DP related determinant detected by primed lymphocyte typing (PLT).
    Odum N; Hofmann B; Hyldig-Nielsen JJ; Jakobsen BK; Morling N; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1987 Feb; 29(2):101-9. PubMed ID: 2440144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Southern blot analysis of HLA-DP gene polymorphisms in Caucasoid rheumatoid arthritis (RA) patients and controls.
    Stephens HA; Vaughan RW; Sakkas LI; Welsh KI; Panayi GS
    Immunogenetics; 1989; 30(3):149-55. PubMed ID: 2476386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II DP epitopes.
    Deng CT; Cai J; Ozawa M; El-Awar N
    Clin Transpl; 2007; ():195-202. PubMed ID: 18637470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
    Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
    Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules.
    de Koster HS; Kenter MJ; D'Amaro J; Luiten RM; Schroeijers WE; Giphart MJ; Termijtelen A
    Immunogenetics; 1991; 34(1):12-22. PubMed ID: 1713190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
    Pesando JM; Graf L; Hoffman P
    J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
    Diedrichs M; Schendel DJ
    J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA DP locus in bone marrow transplantation. Probeless genomic typing of the DPB1 alleles.
    Sorrentino R; Potolicchio I; D'Amato M; Tosi R
    Bone Marrow Transplant; 1993; 11 Suppl 1():17-9. PubMed ID: 8448538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.